# Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging

> **NCT02473250** · PHASE4 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 40 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Fluoxetine
- **DRUG:** Citalopram

## Key facts

- **NCT ID:** NCT02473250
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02473250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02473250, "Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02473250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*